×
TNF Pharmaceuticals Total Assets 2012-2024 | TNFA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
TNF Pharmaceuticals total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
TNF Pharmaceuticals Total Assets 2012-2024 | TNFA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
TNF Pharmaceuticals total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Zoetis (ZTS)
$86.6B
Takeda Pharmaceutical (TAK)
$46.8B
Merck (MKGAF)
$24.9B
Summit Therapeutics (SMMT)
$23.1B
Astellas Pharma (ALPMY)
$21.7B
Sandoz Group AG (SDZNY)
$17.9B
United Therapeutics (UTHR)
$15.1B
Shionogi (SGIOY)
$13.2B
Neurocrine Biosciences (NBIX)
$12.3B
Catalent (CTLT)
$10.8B
Orion OYJ (ORINY)
$7.4B
Revolution Medicines (RVMD)
$7.3B
Jazz Pharmaceuticals (JAZZ)
$6.7B
Ionis Pharmaceuticals (IONS)
$6.2B
Hikma Pharmaceuticals Plc (HKMPF)
$5.7B
Madrigal Pharmaceuticals (MDGL)
$5.3B
Crinetics Pharmaceuticals (CRNX)
$4.3B
Corcept Therapeutics (CORT)
$4B
Dyne Therapeutics (DYN)
$3.4B
Arrowhead Pharmaceuticals (ARWR)
$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.7B
PTC Therapeutics (PTCT)
$2.6B
Catalyst Pharmaceuticals (CPRX)
$2.4B
Soleno Therapeutics (SLNO)
$2.1B
Centessa Pharmaceuticals (CNTA)
$1.9B
Recursion Pharmaceuticals (RXRX)
$1.8B
BioCryst Pharmaceuticals (BCRX)
$1.6B
Harrow (HROW)
$1.6B
Ardelyx (ARDX)
$1.5B
NewAmsterdam Pharma (NAMS)
$1.4B